Stéphane Gennai | Medicine and Health Sciences | Innovative Research Award

Innovative Research Award

Stéphane Gennai
Researcher, University of Reims Champagne-Ardenne (Reims University Hospital), France

Stéphane Gennai
Affiliation University of Reims Champagne-Ardenne (Reims University Hospital)
Country France
Scopus ID 23093862000
Documents 55
Citations 1,267
h-index 14
Subject Area Medicine and Health Sciences
Event Top Teachers Awards
ORCID 0000-0002-8490-4706

Stéphane Gennai is a French emergency medicine physician and university professor affiliated with the University of Reims Champagne-Ardenne and the Reims University Hospital. His research focuses on emergency care, infectious diseases, inflammatory biomarkers, and prehospital management of critically ill patients [1]. He has authored 55 documents indexed in Scopus, accumulating 1,267 citations and an h-index of 14 [2]. His work has contributed to clinical decision-making in emergency departments and the management of SARS-CoV-2 patients [7].

Abstract

This article examines the academic and clinical contributions of Stéphane Gennai, Professor of Universities – Hospital Practitioner at the University of Reims Champagne-Ardenne and the Reims University Hospital. His research addresses emergency medicine, infectious disease management, inflammatory biomarker prescriptions, and prehospital critical care [1]. With 55 Scopus-indexed documents, 1,267 citations, and an h-index of 14, his scholarly output supports evidence-based emergency practice [2]. His contributions have informed clinical decision-making, particularly in the management of SARS-CoV-2 patients and the use of risk-stratification models [7].

Keywords

  • Emergency Medicine, Inflammatory Biomarkers, SARS-CoV-2, Prehospital Care, Clinical Decision-Making, Antibiotic Prescriptions

Introduction

Stéphane Gennai is a prominent figure in French emergency medicine, currently serving as Head of the Emergency and Unscheduled Care Department at the Reims University Hospital since 2023 [1]. He has been affiliated with INSERM Unit UMR-S 1250 (Pulmonary Pathologies and Cellular Plasticity – P3Cell) since 2021 and has held the position of University Coordinator for Emergency Medicine in Champagne-Ardenne since 2019 [2]. His career spans clinical practice, research, and teaching, with a strong focus on improving emergency care through evidence-based research [3].

Research Profile

Stéphane Gennai’s research profile is characterized by a multidisciplinary approach, integrating emergency medicine with infectious diseases, epidemiology, and critical care. He obtained his Habilitation to Supervise Research (HDR) in 2021 and has been a PU-PH since 2022 [1]. His Scopus record includes 55 documents, 1,267 citations, and an h-index of 14, reflecting sustained scholarly impact in Medicine and Health Sciences [2]. He is also a member of the CPD Commission of the French Society of Emergency Medicine and Vice-President of the Grand Est College of Emergency Medicine [3].

Research Contributions

Stéphane Gennai has made significant contributions to emergency medicine research, particularly in the areas of inflammatory biomarker prescriptions, management of transient ischemic attacks, and prehospital care of critically ill patients [4]. His work on the revised HOME-CoV score has provided a risk-stratification model for patients with probable or proven COVID-19 in emergency departments [7]. He has also collaborated on studies evaluating osteopathic treatment for ankle sprains and the use of high-speed trains for mass transfers of critically ill patients [3] [4].

Publications

Stéphane Gennai’s publication record includes numerous peer-reviewed articles in high-impact journals. Notable contributions include the TRANSCOV cohort study on high-speed trains versus air transport for mass transfers of critically ill patients [3], and a study on early osteopathic treatment for acute lateral ankle sprains [4]. His work on smartphone dispatch applications for out-of-hospital cardiac arrest and the BASCULE study on triage in emergency departments further demonstrates his commitment to improving emergency care [5] [6].

Research Impact

The impact of Gennai’s research is evidenced by 1,267 citations and an h-index of 14, indicating that his work is frequently referenced by peers in emergency medicine and related fields [2]. His contributions to the management of SARS-CoV-2 in emergency departments have influenced clinical practice and policy, particularly through the validation of the HOME-CoV score [7]. His research on inflammatory biomarkers has also informed antibiotic stewardship and diagnostic strategies [1].

Award Suitability

Given his extensive research output, clinical leadership, and contributions to emergency medicine, Stéphane Gennai is a strong candidate for the Innovative Research Award at the Top Teachers Awards. His work has advanced the understanding and management of critical conditions in emergency settings, with measurable impact on patient care and clinical decision-making [1] [2]. His dedication to teaching and supervision further underscores his suitability for this recognition [3].

Conclusion

Stéphane Gennai’s career reflects a sustained commitment to advancing emergency medicine through rigorous research, clinical excellence, and education. His Scopus-recorded 55 documents, 1,267 citations, and h-index of 14 attest to his scholarly impact [2]. His contributions to the management of SARS-CoV-2, inflammatory biomarkers, and prehospital care have informed practice and policy, making him a deserving recipient of the Innovative Research Award [7].

References

  1. Elsevier. (n.d.). Scopus author details: Stéphane Gennai, Author ID 23093862000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=23093862000
  2. ORCID. (n.d.). Stéphane Gennai ORCID profile. ORCID.
    https://orcid.org/0000-0002-8490-4706
  3. Thipayamaskomon, C., Grimaud, O., Tattevin, P., Lamhaut, L., Leray, E., Letellier, N., Bayat, S., et al. (2026). High-speed trains versus air transport vectors for mass transfers of critically ill patients: The TRANSCOV cohort study. PLOS ONE.
    DOI: https://doi.org/10.1371/journal.pone.0348090
  4. Bournon, C., Prin-Conti, D., Douay, J., Montfajon, P. A., Kanagaratnam, L., & Gennai, S. (2026). Early osteopathic treatment delivered to patients with an acute lateral ankle sprain improves recovery: An investigative study. Journal of Osteopathic Medicine.
    DOI: https://doi.org/10.1515/jom-2025-0096
  5. Soumagnac, T., Soumagnac, M. T., Raphalen, J. H., Hutin, A., Lamhaut, L., Bossaert, C., Dolveck, F., et al. (2025). What to expect from a smartphone dispatch application for out-of-hospital cardiac arrest in a national population? Resuscitation.
    DOI: https://doi.org/10.1016/j.resuscitation.2025.110887
  6. Bilbault, P., Bronner, C., Etienne, A., Goudour, J., Dagtekin, S., Maire, B., Gennai, S., Chouihed, T., et al. (2025). BASCULE study: Is it possible to refer patients after triage in an emergency department to community medicine from a capacity standpoint for general medicine? Annales Françaises de Médecine d’Urgence.
    DOI: https://www.jle.com/10.1684/afmu.2025.0694
  7. Douillet, D., Riou, J., Morin, F., Mahieu, R., Chauvin, A., Gennai, S., Ferrant, L., Lopez, R., Sebbane, M., et al. (2024). Derivation and validation of a risk-stratification model for patients with probable or proven COVID-19 in EDs: The revised HOME-CoV score. Emergency Medicine Journal, 41(4), 218–225.
    DOI: https://doi.org/10.1136/emermed-2022-212805

Hanseob Shin | Antimicrobial | Best Researcher Award

Dr. HanseobShin | Antimicrobial | Best Researcher Award

Postdoc scholar at University of iowa,United States

Dr. Hanseob Shin is a dedicated environmental microbiologist specializing in tracking environmental contamination, microbial ecology, and antimicrobial resistance in water systems. As a Postdoctoral Fellow at the Center for Health Effects of Environmental Contamination at the University of Iowa, he actively investigates the fate and transport of antibiotic-resistant bacteria in various aquatic environments. His research applies CRISPR spacerome analysis and microbial source tracking to understand the dynamics of contamination sources. With extensive experience in environmental microbiology, Dr. Shin has contributed significantly to identifying antibiotic-resistant genes in wastewater and river systems, improving public health risk assessment. He has authored numerous scientific publications in prestigious journals and actively participates in national and international conferences. Through his research, he aims to develop innovative solutions for mitigating microbial contamination in natural and engineered water systems, promoting environmental sustainability and health protection.

Professional Profile

Scopus Profile

ORCID

Education 🎓

Dr. Hanseob Shin obtained his Ph.D. in Earth Sciences and Environmental Engineering from the Gwangju Institute of Science and Technology, South Korea, in 2022. His doctoral research focused on long-term monitoring of antibiotic resistance genes and bacteria in rivers and wastewater treatment plants, providing valuable insights into microbial contamination dynamics. Before his Ph.D., he earned a Bachelor of Science in Molecular Biotechnology from Chonnam National University in 2015, where he developed a strong foundation in microbial genetics and biotechnology. His academic journey has been marked by a keen interest in microbial ecology, antibiotic resistance, and environmental health. Dr. Shin’s education has equipped him with expertise in advanced microbiological techniques, including metagenomics, CRISPR engineering, and microbial source tracking. His interdisciplinary training bridges environmental science and molecular biotechnology, enabling him to address pressing challenges in water quality management and public health protection.

Work Experience 💼

Dr. Hanseob Shin has accumulated extensive experience in environmental microbiology and microbial source tracking. Since 2022, he has been a Postdoctoral Fellow at the Center for Health Effects of Environmental Contamination at the University of Iowa, where he investigates antimicrobial resistance in water systems. Prior to this, he worked as a Postdoctoral Research Associate at the Gwangju Institute of Science and Technology, contributing to research on microbial contamination in wastewater treatment plants. His work has involved the application of molecular and genomic tools to study antibiotic-resistant bacteria in environmental settings. Additionally, he has collaborated with government agencies and research institutions to assess microbial contamination in agricultural and urban water sources. Through his academic and research roles, Dr. Shin has developed a strong expertise in microbial ecology, CRISPR-based bacterial identification, and the environmental impact of antibiotic resistance genes.

Research Interests 🔬

Dr. Hanseob Shin’s research is centered on environmental microbiology, microbial ecology, and the fate and transport of antimicrobial resistance in water systems. He investigates the spread of antibiotic-resistant bacteria in aquatic environments, including wastewater treatment plants, rivers, and agricultural runoff. His work utilizes CRISPR spacerome analysis for strain-level bacterial identification and microbial source tracking to trace contamination origins. Dr. Shin also explores the role of core antibiotic resistance genes as indicators of pollution in wastewater and natural water bodies. His studies contribute to improving strategies for mitigating microbial risks in water systems. Additionally, he examines the genetic diversity of antibiotic-resistant bacteria, aiming to understand their persistence and potential health risks. His research has practical applications in public health, environmental policy, and water treatment technologies, promoting safer water resources and sustainable environmental management.

Awards & Achievements 🏆

Dr. Hanseob Shin has received recognition for his outstanding research contributions in environmental microbiology. In 2022, he was awarded the Outstanding Best Poster Award at the International Symposium and Annual Meeting of the KSABC for his work on antibiotic resistance genes in effluent and receiving water. His research projects have secured significant funding, including a $300,000 grant from the Chicago Community Trust for studying antibiotic-resistant bacteria in Iowa’s concentrated animal feeding operations (CAFOs). He has also received substantial research grants from the Rural Development Administration and the Korea Environmental Industry & Technology Institute for projects related to wastewater treatment and antibiotic-resistant organisms. His contributions as a peer reviewer for high-impact journals further highlight his expertise in the field. Dr. Shin’s accolades reflect his dedication to advancing scientific knowledge on microbial contamination and public health.

Conclusion

Dr. Hanseob Shin is a strong candidate for the Best Researcher Award due to his impactful contributions to environmental microbiology, antibiotic resistance, and microbial tracking. His extensive publication record, research funding, and conference presentations position him as an emerging leader in his field. While he could enhance his profile by expanding his independent research leadership and mentorship roles, his current achievements make him a highly competitive nominee for this prestigious award.

Top Noted Publications 📚

Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance

Authors: Not specified

Year: 2022

Citations: Not specified

Prevalence and Characterization of CRISPR Locus 2.1 Spacers in Escherichia coli Isolates Obtained from Feces of Animals and Humans

Authors: Not specified

Year: 2023

Citations: Not specified

Resistome Study in Aquatic Environments

Authors: Not specified

Year: 2023

Citations: Not specified

Dynamics of Genotypic and Phenotypic Antibiotic Resistance in a Conventional Wastewater Treatment Plant in 2 Years

Authors: Not specified

Year: 2022

Citations: Not specified

Geographical distribution and genetic diversity of Bradyrhizobium spp. isolated from Korean soybean root nodules

Authors: Not specified

Year: 2022

Citations: Not specified

Higher abundance of core antimicrobial resistant genes in effluent from wastewater treatment plants

Authors: Not specified

Year: 2022

Citations: Not specified

Phylogenetic diversity and spatiotemporal dynamics of bacterial and microeukaryotic plankton communities in Gwangyang Bay of the Korean Peninsula

Authors: Not specified

Year: 2022

Citations: Not specified

Emergence of High Level Carbapenem and Extensively Drug Resistant Escherichia coli ST746 Producing NDM-5 in Influent of Wastewater Treatment Plant, Seoul, South Korea

Authors: Not specified

Year: 2021

Citations: Not specified

Metagenomic exploration of antibiotic resistome in treated wastewater effluents and their receiving water

Authors: Not specified

Year: 2021

Citations: Not specified

High genetic diversity of Vibrio parahaemolyticus isolated from tidal water and mud of southern coast of South Korea

Authors: Not specified

Year: 2019

Citations: Not specified

Metagenomic analysis reveals the prevalence and persistence of antibiotic- and heavy metal-resistance genes in wastewater treatment plant

Authors: Not specified

Year: 2018

Citations: Not specified